Ms Julia Chapman > Dechert LLP > Philadelphia, United States > Lawyer Profile
Dechert LLP Offices
CIRCA CENTRE, 2929 ARCH STREET
PHILADELPHIA, PA 19104-2808
PENNSYLVANIA
United States
- Firm Profile
- Go to...
Ms Julia Chapman
Work Department
Antitrust/Competition
Position
Partner
Career
Julia Chapman is a litigator who represents clients in antitrust, competition, and commercial litigation matters. She handles complex cases across the country through all stages of litigation, from early dispositive motions through trial. Julia has a track record of developing creative arguments for early-stage dismissal and uses her antitrust trial experience to drive strategy and factual development from day-one of every case. Julia also represents clients in government and internal investigations. Julia has experience in a wide variety of industries, ranging from life sciences to technology to financial services.
Julia is committed to her pro bono civil rights practice. She has represented various state conferences of the NAACP in challenges to restrictive voting laws around the country and has led settlement negotiations that resulted in restored and expanded access to the right to vote. Julia also regularly represents incarcerated and formerly incarcerated individuals in civil rights actions, appeals and resentencing proceedings.
Education
- Pennsylvania State University, B.A., 2009, With Honors
- Georgetown University Law Center, B.L, 2013, cum laude, Editor-in-Chief of the Annual Survey of White Collar Crime, a publication of the American Criminal Law Review
Lawyer Rankings
United States > Antitrust > Civil litigation/class actions: defense
Dechert LLP offers global and nationwide antitrust capabilities to its growing client base which features names such as Endo Pharmaceuticals and Marriott International. The firm is well-versed with a range of litigation including conspiracies related to advertising, bid rigging and price fixing as well as antitrust patent litigation and rule of reason standards. Based in Philadelphia is co-head Steven Bizar, who focuses his practice on trial work, particularly antitrust and trade regulation and is well-regarded for his success in defending against section 1 and 2 Sherman Act cases and class action lawsuits. Also co-heading the team from Washington DC is Mike Cowie, a healthcare and life sciences law expert who focuses on government merger investigations and litigation. Also in Philadelphia are George G Gordon who has significant experience in representing companies in class actions and investigations concerning patent enforcement, pricing concerns and marketing, and Julia Chapman, who is well-versed in all stages of litigation particularly in the life sciences, specialty chemicals and tech fields. Experienced trial lawyer Shari Ross Lahlou, based in DC, acts for Fortune 500 clients including Johnson & Johnson. The group has expanded its team and strengthened its high-tech antitrust expertise with the hires from Orrick, Herrington & Sutcliffe LLP in January 2023 including Jay Jurata in DC, former head of Orrick’s antitrust and competition group, Russell Cohen and Howard Ullman in the San Francisco office.
Lawyer Rankings
Top Tier Firm Rankings
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Tax > International tax
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > International arbitration
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Financial services litigation